To The Moon

$General Motors(GM)$ is scheduled to release its fourth-quarter and full-year 2025 financial results on Tuesday, January 27, 2026, before the market opens. Coming off a strong 2025 where GM reclaimed its title as the top-selling automaker in the U.S., the Q4 report will be a balancing act between resilient internal combustion engine (ICE) profits and a significant "EV strategy reset." Key Expectations & Estimates Earnings Per Share (EPS): Analysts expect an adjusted EPS of approximately $2.19, a notable increase from $1.92 in Q4 2024. Revenue: Consensuses are pegged at roughly $45 billion, which would represent a ~6% decline year-over-year. Special Charges: GM will record roughly $6 billion in one-time charges related to its EV rollback and stra

Executive Summary $Seagate Technology PLC(STX)$ reports fiscal Q2 2026 earnings Monday, January 27, after the bell. Consensus calls for $2.76 EPS on $2.73 billion revenue. Our proprietary Entry Indicator is -1.00, flagging severe structural weakness despite the stock trading near 52-week highs at $346. The options market prices in a 9.78% earnings move. That's your corridor: $373.17 to $305.49. The stock sits $26.10 above Max Pain at $320. The Put/Call ratio at 2.21 shows traders are loading up on downside protection. The magnet is pulling hard. The Earnings Risk Corridor: 9.78% Expected Move The market expects STX to swing $33.86 in either direction post-earnings. Upper bound at $373.17. Lower bound at $305.49. This is double the volatility we saw

$IREN Ltd(IREN)$ sharing for coins. have faith in crypto

Executive Summary $UnitedHealth(UNH)$ reports Q4 2025 and full-year results Monday, January 27, before the bell. Consensus calls for $2.09 per share on $113.64 billion in revenue. That's a 69.3% earnings collapse from Q4 2024. Our proprietary Entry Indicator sits at -1.00, the most bearish signal possible, flagging structural breakdown. The options market prices in a 4.77% earnings move. That's your corridor: $369.86 to $335.85. The stock sits at $356.26, a full $16.26 above Max Pain at $340. Dealers are pulling the stock toward that level. This is a profitability crisis, not a revenue story. The Earnings Risk Corridor: 4.77% Expected Move The market expects UNH to swing $16.99 in either direction post-earnings. Upper bound at $369.86. Lower bound

$Microsoft(MSFT)$  $Meta Platforms, Inc.(META)$  $Tesla Motors(TSLA)$  💼 Earnings concentration, volatility expansion, and dispersion risk Next week sets up as a high-dispersion, flow-led market environment where mega-cap earnings, macro catalysts, and options positioning converge. This is not a single-stock tape. It is a cross-sector liquidity event where correlations can fracture, leadership can rotate, gamma can flip intraday, and volatility becomes a strategic edge. In regimes like this, capital flow, positioning, liquidity pockets, and factor rotation matte

Software stocks such as Microsoft will rebound on earnings on 29/01/2026

$Intuitive Surgical(ISRG)$ is scheduled to report its fiscal Q4 2025 earnings on Thursday, January 22, 2026, after the market close. Because the company released preliminary results on January 14, much of the revenue data is already known. This shifts the focus of the actual earnings call toward margins, profitability, and 2026 guidance. Q4 2025 Preliminary Numbers (Known) Revenue: ~$2.87 billion (up 19% YoY), beating the $2.73B consensus. Procedure Growth: Worldwide da Vinci/Ion procedures grew ~18%. System Placements: 532 systems placed (vs. 493 last year), including 303 da Vinci 5 (dV5) systems. Ion Growth: Ion procedures surged ~44% YoY, showing strong diversification beyond soft-tissue robotics. Intuitive Surgical (ISRG) reported its Fiscal Q

🚨 Record Inflows Meet Sector Rotation: Is the Market Bracing for a Shift? While the headline indices felt choppy last week, looking under the hood reveals a very different story. We saw a massive divergence between price action (muted) and capital flows (explosive). Institutions aren't leaving the casino—they are just moving to different tables. If you’re still 100% heavy on big tech and ignoring the signals from the bond and commodity markets, you might be missing the next leg of this cycle. Here is the deep dive on last week's ETF trends and what they tell us about the smart money’s playbook for late January. 1️⃣ The "Silent" Buy-the-Dip: Huge Inflows into S&P 500 Despite the S&P 500 feeling suppressed, the flow data shows "Aggressive Accumulation." We saw massive capital injecti

this is good and useful information

This is cool and stews 

We saw how “Sell America” went into full swing in Tuesday (20 Jan) trading session, major indices like DJIA lost 870 points, S&P 500 drops 2% for worst day since October on Trump tariff threat over Greenland. With the Q4 earnings season coming for most major names, I think we can look at some of the sector which seems to be affected the least, one of them is Healthcare. One of names we can look at is $Abbott Laboratories(ABT)$ upcoming Fiscal Q4 2025 earnings which is estimated to be on Thursday, January 22, 2026 (Before Market Open). Earnings Release Details Consensus EPS Estimate: $1.50 (implying ~11.9% year-over-year growth) Consensus Revenue Estimate: $11.79 Billion (implying ~7.5% year-over-year growth) Based on the Fiscal Q3 2025 report r

The economy is in golden locks cycle & availability for credit is excellent Boom baby 

During this earnings season, with mixed signals from the S&P 500 and stretched valuations, key areas to focus on include: Overall S&P 500 Performance: Monitor the blended Q4 earnings growth, which stands at 8.2%, and revenue growth of 7.8%. While these figures indicate solid growth and a potential 10th consecutive quarter of year-over-year growth, revenues are still below long-term averages. Sectoral Performance: Pay close attention to sectors like Information Technology and Materials, which are leading the growth. Conversely, analyze the performance of lagging sectors such as Energy and Consumer Discretionary. Valuation vs. Earnings Growth: Given that the forward P/E has climbed to 22.2, well above historical norms, assess whether the strong earnings growth, particularly from lead

I own a lot of bank and investment bank stocks plus Amex, visa and sofi. All have have an annualized return of over 50% and a third over 100%. Well by all, I mean all but one. Visa has sucked, oh wait if I lump PayPal in there to, it’s very suckie. My annualized return on visa is -1% give or take. PayPal is like -20%. But pretty insignificant compared to overall gains. But as I looks through my investment notes, it clear. $Citigroup(C)$ was a no brainer. And old fashioned value stock when I brought it. David Dodd would be proud. It was trading at around half of its break up value when I brought it. You never find stocks like that these days. But find it I did. I brought ALOt of different bank stocks during the “banking crisis” around two years ago.

nice

I’ve been thinking a lot about Flagstar Financial (FLG) recently, mostly because their stock is releasing earnings on January 30, 2026. I’m not planning to buy—at least, not yet—but there’s a part of me that can’t help checking. There’s something quietly compelling about watching a company’s story unfold through numbers, seeing whether strategy, effort, and past decisions finally come together. Flagstar Financial, Inc. (FLG) Flagstar’s recent years have been…well, full of changes. Back in April 2021, New York Community Bancorp announced it was acquiring Flagstar in an all-stock merger. It wasn’t a fast process—the deal completed only in December 2022. But then, just a few months later, in March 2023, Flagstar absorbed nearly all of Signature Bank’s deposits after Signature collapsed. I sti

1) Does JPMorgan’s miss signal a broader capital markets slowdown? It can, but it is more “uneven recovery” than a full downturn. Investment banking is highly cyclical: If JPM’s IB revenue came in below guidance, it often reflects slower deal-making (M&A) and more cautious underwriting (IPOs, bonds) across the street, not just a firm-specific issue. High rates delay decisions: Higher discount rates make valuations harder to agree on, so CEOs and PE funds tend to wait longer, pushing deal timelines out. Trading can mask weakness: Even when IB is soft, markets revenue (FICC/equities trading) can hold up. So the signal is: deal activity is not rebounding as fast as hoped, not that the entire capital markets engine has stalled. Bottom line: JPM’s miss likely supports the view that capital

JPMorgan's Earnings and Capital Markets Activity JPMorgan Chase's Q4 2025 earnings showed a mixed picture. While its profit exceeded estimates due to a trading boom in volatile markets, with equities revenue surging 40% and fixed income climbing 7%, its investment banking fees fell 5% and missed Wall Street estimates by 8%. This led to an initial decline in JPM's shares and contributed to the broader financial sector moving lower. Despite the dip in JPMorgan's investment banking fees, the overall outlook for capital markets activity appears more nuanced. Investment banking revenues for the industry are generally expected to be up, particularly in equity capital markets. The U.S. IPO market reached its highest level in 2025 since 2021. KBW anticipates continued momentum and outperformance i

🌟🌟Certainty or Transformation?  The banks are split into 2 narratives.  Transformation: Citi & Wells Fargo announcing layoffs while increasing their AI investments, signal a familiar pattern in banking: streamline cost base, modernise infrastructure & hope the transformation is successful.  These moves can translate into long term profitability but the payoff depends on execution & whether legacy systems can be merged well. High potential, high complexity. Certainty: Certainty names like Goldman Sachs & Bank of America operate like wellrun machines.  Predictable earnings &diversified revenue streams.They are steady, reliable & less dramatic. Which camp am I in? Neither. I am in the disciplined camp.  I don't chase narratives. I don't pick f

Short take: Probably not a great trade for 2026 — at least not yet.The proposed 10% cap on credit card rates would seriously hurt the biggest earners in the space (think Capital One, Amex, Discover, even some of the big banks’ card divisions). That’s a massive hit to their highest-margin business, and the market already priced in a pretty ugly reaction when Trump floated it.If the cap actually gets passed and sticks for the full year, I’d expect more pain and lower multiples for those names. On the flip side, if it gets watered down, delayed, or quietly killed in Congress/bureaucracy (which is very possible), then the stocks could bounce hard from these depressed levels.Right now it feels more like a high-risk “fade the fear” play than a clean bullish setup. I’d wait for more clarity befor

$General Motors(GM)$ is scheduled to release its fourth-quarter and full-year 2025 financial results on Tuesday, January 27, 2026, before the market opens. Coming off a strong 2025 where GM reclaimed its title as the top-selling automaker in the U.S., the Q4 report will be a balancing act between resilient internal combustion engine (ICE) profits and a significant "EV strategy reset." Key Expectations & Estimates Earnings Per Share (EPS): Analysts expect an adjusted EPS of approximately $2.19, a notable increase from $1.92 in Q4 2024. Revenue: Consensuses are pegged at roughly $45 billion, which would represent a ~6% decline year-over-year. Special Charges: GM will record roughly $6 billion in one-time charges related to its EV rollback and stra

Executive Summary $Seagate Technology PLC(STX)$ reports fiscal Q2 2026 earnings Monday, January 27, after the bell. Consensus calls for $2.76 EPS on $2.73 billion revenue. Our proprietary Entry Indicator is -1.00, flagging severe structural weakness despite the stock trading near 52-week highs at $346. The options market prices in a 9.78% earnings move. That's your corridor: $373.17 to $305.49. The stock sits $26.10 above Max Pain at $320. The Put/Call ratio at 2.21 shows traders are loading up on downside protection. The magnet is pulling hard. The Earnings Risk Corridor: 9.78% Expected Move The market expects STX to swing $33.86 in either direction post-earnings. Upper bound at $373.17. Lower bound at $305.49. This is double the volatility we saw

Executive Summary $UnitedHealth(UNH)$ reports Q4 2025 and full-year results Monday, January 27, before the bell. Consensus calls for $2.09 per share on $113.64 billion in revenue. That's a 69.3% earnings collapse from Q4 2024. Our proprietary Entry Indicator sits at -1.00, the most bearish signal possible, flagging structural breakdown. The options market prices in a 4.77% earnings move. That's your corridor: $369.86 to $335.85. The stock sits at $356.26, a full $16.26 above Max Pain at $340. Dealers are pulling the stock toward that level. This is a profitability crisis, not a revenue story. The Earnings Risk Corridor: 4.77% Expected Move The market expects UNH to swing $16.99 in either direction post-earnings. Upper bound at $369.86. Lower bound

$Microsoft(MSFT)$  $Meta Platforms, Inc.(META)$  $Tesla Motors(TSLA)$  💼 Earnings concentration, volatility expansion, and dispersion risk Next week sets up as a high-dispersion, flow-led market environment where mega-cap earnings, macro catalysts, and options positioning converge. This is not a single-stock tape. It is a cross-sector liquidity event where correlations can fracture, leadership can rotate, gamma can flip intraday, and volatility becomes a strategic edge. In regimes like this, capital flow, positioning, liquidity pockets, and factor rotation matte

$Intuitive Surgical(ISRG)$ is scheduled to report its fiscal Q4 2025 earnings on Thursday, January 22, 2026, after the market close. Because the company released preliminary results on January 14, much of the revenue data is already known. This shifts the focus of the actual earnings call toward margins, profitability, and 2026 guidance. Q4 2025 Preliminary Numbers (Known) Revenue: ~$2.87 billion (up 19% YoY), beating the $2.73B consensus. Procedure Growth: Worldwide da Vinci/Ion procedures grew ~18%. System Placements: 532 systems placed (vs. 493 last year), including 303 da Vinci 5 (dV5) systems. Ion Growth: Ion procedures surged ~44% YoY, showing strong diversification beyond soft-tissue robotics. Intuitive Surgical (ISRG) reported its Fiscal Q

$IREN Ltd(IREN)$ sharing for coins. have faith in crypto

We saw how “Sell America” went into full swing in Tuesday (20 Jan) trading session, major indices like DJIA lost 870 points, S&P 500 drops 2% for worst day since October on Trump tariff threat over Greenland. With the Q4 earnings season coming for most major names, I think we can look at some of the sector which seems to be affected the least, one of them is Healthcare. One of names we can look at is $Abbott Laboratories(ABT)$ upcoming Fiscal Q4 2025 earnings which is estimated to be on Thursday, January 22, 2026 (Before Market Open). Earnings Release Details Consensus EPS Estimate: $1.50 (implying ~11.9% year-over-year growth) Consensus Revenue Estimate: $11.79 Billion (implying ~7.5% year-over-year growth) Based on the Fiscal Q3 2025 report r

🚨 Record Inflows Meet Sector Rotation: Is the Market Bracing for a Shift? While the headline indices felt choppy last week, looking under the hood reveals a very different story. We saw a massive divergence between price action (muted) and capital flows (explosive). Institutions aren't leaving the casino—they are just moving to different tables. If you’re still 100% heavy on big tech and ignoring the signals from the bond and commodity markets, you might be missing the next leg of this cycle. Here is the deep dive on last week's ETF trends and what they tell us about the smart money’s playbook for late January. 1️⃣ The "Silent" Buy-the-Dip: Huge Inflows into S&P 500 Despite the S&P 500 feeling suppressed, the flow data shows "Aggressive Accumulation." We saw massive capital injecti

Software stocks such as Microsoft will rebound on earnings on 29/01/2026

this is good and useful information

The economy is in golden locks cycle & availability for credit is excellent Boom baby 

This is cool and stews 

$Goldman Sachs(GS)$ is scheduled to report its fiscal Q4 2025 earnings on Thursday, January 15, 2026, before the market opens. The bank enters this report following a massive rally—shares are up roughly 65% over the last 12 months—and is trading near all-time highs (around $940–$950). This sets a high bar for performance, as much of the "dealmaking renaissance" may already be priced in. Key Consensus Estimates (Q4 2025) Earnings Per Share (EPS): ~$11.69 (Revisions have trended upward by 6% in the last 30 days). Revenue: ~$14.54 billion (Expected growth of ~4.8% YoY). Implied Move: Options markets suggest a potential stock move of +/- 4.5% to 5.5% post-earnings. Goldman Sachs reported its fiscal Q3 2025 results on October 14, 2025. The quarter was ch

During the January 2026 super earnings week, America’s major banks have all reported results. While each bank has a different business focus, one industry-wide consensus has clearly emerged: short-term expense increases in the name of future technology (AI).The market’s response, however, has been brutally pragmatic. Tolerance for rising costs is fading, and the ROI (return on investment) stress test has officially begun.AI transformation vs. operating expense growth has become the core “battleground” of this earnings season.1. $JPMorgan Chase(JPM)$: The bold “long-term tech bet”CEO Jamie Dimon has taken a firm stance on higher spending — essentially telling investors, “Trust me.” He argues that investing now in AI, data centers, and cybersecurity

The January 2026 earnings season has started on a rough note for U.S. banks.All major US banks have now reported their results. Although each bank has a different business focus, increasing short-term spending on future technologies, particularly AI, has become an industry-wide consensus.However, the market’s reaction has been notably pragmatic: tolerance for rising expenses is fading, and the test of ROI (return on investment) has officially begun.Management teams repeatedly emphasized AI, data centers, and automation as long-term necessities. But the market is no longer rewarding spending on trust alone.Big bank earnings brief$Bank of America(BAC)$ delivered both EPS and revenue beats, supported by strong equity trading and a ~10% YoY increase in

$Bank of America(BAC)$'s Q4 2025 earnings are scheduled for release on Wednesday, January 14, 2026, before the market opens, with a conference call following at approximately 8:30 a.m. ET. This report covers the period from October to December 2025, wrapping up a year where the banking sector benefited from resilient economic conditions, stabilizing interest rates, and a rebound in dealmaking activity. BAC shares have performed strongly in 2025, outperforming the S&P 500 with a roughly 18% return over the past six months, trading around $55–$57 recently amid broader market volatility. Consensus Expectations and Year-Over-Year Comparison Analysts are forecasting a solid quarter, driven by improved net interest margins, loan growth, and higher in

🌟🌟🌟When JPMorgan $JPMorgan Chase(JPM)$  the bellwether of the financial sector, reported earnings that fall short on investment banking revenues, the whole sector feels it.  On Tuesday, JPMorgan's shares slid more than 4%, pulling the broader financial sector down with it. Everyone is now asking the same question: Is this a blip or the beginning of a broader slowdown in capital markets activity? Just as Wall Street was processing that, President Trump threw another curve ball into the sector: A proposed 10% cap on credit card interest rates. This unexpected move sent credit card lenders tumbling as investors braced for the potential hit to profitability. JPMorgan's Miss: A Canary in the Capital Markets Coal

Though tech stocks make a recovery on Thursday (15 Jan) after TSMC stellar earnings and guidance outlook, but we are still seeing tech and banks facing sector rotation in earnings week. Financials managed to make a recovery last night as well, but could this rotation continue in the next few weeks as more earnings are coming? In this article, we would like to look at the comprehensive market- and strategy-focused overview of your questions around the current tech vs financial rotation, geopolitical export restrictions, and tactical portfolio positioning: Market context (Thursday, 15 January 2026) • Stocks broadly recovered after recent losses, fueled by strong $Taiwan Semiconductor Manufacturing(TSM)$ earnings and guidance, which lifted semiconduct

$JPMorgan Chase(JPM)$ is scheduled to report its fiscal Q4 2025 earnings on Tuesday, January 13, 2026, before the market opens. As the bellwether for the banking sector, JPM’s results will set the tone for the 2026 outlook. Analysts have recently revised earnings estimates upward, reflecting a "high-bar" setup where a simple beat might not be enough to drive the stock higher if the forward guidance is cautious. JPMorgan Chase (JPM) delivered a strong fiscal Q3 2025 performance, beating analyst expectations on both the top and bottom lines. However, the report was a classic case of "strong numbers, cautious outlook," as management used the call to reset expectations for 2026. Q3 2025 Financial Summary Earnings per Share (EPS): $5.07 (vs. $4.84 expec

$Genprex, Inc.(GNPX)$   The Genprex Inc. stock price gained 19.58% on the last trading day (Wednesday, 14th Jan 2026), rising from $2.40 to $2.87. During the last trading day the stock fluctuated 36.67% from a day low at $2.10 to a day high of $2.87. The price has risen in 7 of the last 10 days and is up by 63.07% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $5.71 million. The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to th